Big pharma inspection flunkies; packagers and repackagers unite;

> Abbott Labs failed 59 percent of 111 inspections; Pfizer flunked 57 percent of 202 inspections; Merck bombed out on 52 percent of 134 visits and Johnson & Johnson failed 48 percent of 161 inspections. Story

> Aphena Pharma Solutions combines four packagers and repackagers: Celeste Contract Packaging, PrePak Systems, TestPak and Integrated Pharmaceutical Packaging. Release

> Contract manufacturer SCM Pharma is expanding its U.K. footprint to meet growing U.S. demand for high-potency drugs. Article

> Genzyme and International Chemical Investors Group have closed the deal: ICIG now owns the pharma intermediates business and has renamed it Corden Pharma Switzerland. Release

> Rwanda is getting a $65-million pharma manufacturing plant thanks to a partnership between Cadila of India and U.S.-based Holtzman group. Story

> Almac is now equipped to package, store and distribute schedule I-V controlled substances at its Souderton, PA, facility. Release

> A University of Wisconsin chemistry professor is investigating the use of air as an environmentally benign oxidant for pharmaceutical synthesis. Story

> The FDA wants drugmakers to consider removing zinc from denture cream due to a possible link between neurological problems and zinc poisoning. Article

> Merck's expansion of a clinical supplies manufacturing, packaging and warehouse operations in Summit, NJ, has earned a Facility of the Year Award from ISPE, INTERPHEX and Pharmaceutical Processing. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.